← All Sponsors
SPONSOR

Chongqing Precision Biotech Co., Ltd

Total Trials
7
Recruiting
7
Phases
Phase 1
Conditions studied: Gastric CancerColon CancerPancreas CancerEsophagus CancerCholangiocarcinomaLung CancerBreast CancerAdvanced Lung CancerRenal Cell Carcinoma (RCC)Anaplastic Thyroid Carcinomas
NCT06010862 Phase 1
Recruiting

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Gastric Cancer
China View Trial →
NCT06768151 Phase 1
Recruiting

A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer

Advanced Lung Cancer
China View Trial →
NCT07181720 Phase 1
Recruiting

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Renal Cell Carcinoma (RCC)
China View Trial →
NCT06945523 Phase 1
Recruiting

Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer

Advanced Lung Cancer
China View Trial →
NCT07184450 Phase 1
Recruiting

Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

Juvenile Dermatomyositis (JDM)
China View Trial →
NCT06992583 Phase 1
Recruiting

Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer

Advanced Lung Cancer
China View Trial →
NCT06180174 Phase 1
Recruiting

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

B Cell Lymphoma
China View Trial →